BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 28726212)

  • 21. Melasma.
    Wu IB; Lambert C; Lotti TM; Hercogová J; Sintim-Damoa A; Schwartz RA
    G Ital Dermatol Venereol; 2012 Aug; 147(4):413-8. PubMed ID: 23007216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion.
    Sofen B; Prado G; Emer J
    Skin Therapy Lett; 2016 Jan; 21(1):1-7. PubMed ID: 27224897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding Melasma-How Can Pharmacology and Cosmetology Procedures and Prevention Help to Achieve Optimal Treatment Results? A Narrative Review.
    Piętowska Z; Nowicka D; Szepietowski JC
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the treatment of melasma: a review of the recent literature.
    Ball Arefiev KL; Hantash BM
    Dermatol Surg; 2012 Jul; 38(7 Pt 1):971-84. PubMed ID: 22583339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polypodium leucotomos as an Adjunct Treatment of Pigmentary Disorders.
    Nestor M; Bucay V; Callender V; Cohen JL; Sadick N; Waldorf H
    J Clin Aesthet Dermatol; 2014 Mar; 7(3):13-7. PubMed ID: 24688621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study.
    Attwa E; Khater M; Assaf M; Haleem MA
    Int J Dermatol; 2015 Feb; 54(2):235-44. PubMed ID: 25266556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New oral and topical approaches for the treatment of melasma.
    Grimes PE; Ijaz S; Nashawati R; Kwak D
    Int J Womens Dermatol; 2019 Feb; 5(1):30-36. PubMed ID: 30809577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of hyperpigmentation in darker racial ethnic groups.
    Grimes PE
    Semin Cutan Med Surg; 2009 Jun; 28(2):77-85. PubMed ID: 19608057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melasma: systematic review of the systemic treatments.
    Zhou LL; Baibergenova A
    Int J Dermatol; 2017 Sep; 56(9):902-908. PubMed ID: 28239840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical and Systemic Therapies in Melasma: A Systematic Review.
    Sarkar R; Handog EB; Das A; Bansal A; Macarayo MJ; Keshavmurthy V; Narayan V; Jagadeesan S; Pipo E; Ibaviosa GM; Podder I; Bansal S
    Indian Dermatol Online J; 2023; 14(6):769-781. PubMed ID: 38099013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melasma: a review.
    Victor FC; Gelber J; Rao B
    J Cutan Med Surg; 2004; 8(2):97-102. PubMed ID: 15685388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethnic considerations in the treatment of Hispanic and Latin-American patients with hyperpigmentation.
    Hexsel D; Arellano I; Rendon M
    Br J Dermatol; 2006 Dec; 156 Suppl 1():7-12. PubMed ID: 17176299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of systemic treatments for skin lightening.
    Juhasz MLW; Levin MK
    J Cosmet Dermatol; 2018 Dec; 17(6):1144-1157. PubMed ID: 30133125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathological comparison of lesional and perilesional skin in melasma: A cross-sectional analysis.
    Gautam M; Patil S; Nadkarni N; Sandhu M; Godse K; Setia M
    Indian J Dermatol Venereol Leprol; 2019; 85(4):367-373. PubMed ID: 30516167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of melasma: a review of less commonly used antioxidants.
    Babbush KM; Babbush RA; Khachemoune A
    Int J Dermatol; 2021 Feb; 60(2):166-173. PubMed ID: 32815582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind, Placebo-controlled Trial to Evaluate the Effectiveness of
    Goh CL; Chuah SY; Tien S; Thng G; Vitale MA; Delgado-Rubin A
    J Clin Aesthet Dermatol; 2018 Mar; 11(3):14-19. PubMed ID: 29606995
    [No Abstract]   [Full Text] [Related]  

  • 37. A review of laser and light therapy in melasma.
    Trivedi MK; Yang FC; Cho BK
    Int J Womens Dermatol; 2017 Mar; 3(1):11-20. PubMed ID: 28492049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melasma: histopathological characteristics in 56 Korean patients.
    Kang WH; Yoon KH; Lee ES; Kim J; Lee KB; Yim H; Sohn S; Im S
    Br J Dermatol; 2002 Feb; 146(2):228-37. PubMed ID: 11903232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newer and upcoming therapies for melasma.
    Sarkar R; Chugh S; Garg VK
    Indian J Dermatol Venereol Leprol; 2012; 78(4):417-28. PubMed ID: 22772611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of combined treatments for melasma involving energy-based devices and proposed pathogenesis-oriented combinations.
    Mehrabi JN; Bar-Ilan E; Wasim S; Koren A; Zusmanovitch L; Salameh F; Isman Nelkenbaum G; Horovitz T; Zur E; Song Lim T; Mashiah J; Artzi O
    J Cosmet Dermatol; 2022 Feb; 21(2):461-472. PubMed ID: 33794033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.